AVI-014
- Generic Name
- AVI-014
- Drug Type
- Biotech
- Background
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2011-05-03
- Lead Sponsor
- AviGenics
- Target Recruit Count
- 189
- Registration Number
- NCT00497809
- Locations
- 🇺🇸
Cancer Care Institute of Carolina, Aiken, South Carolina, United States
🇮🇳Mohan Dai Oswal Cancer Treatment & Research Foundation, G.T. Road, Sherpur Bye Pass, Ludhiana, India
🇮🇳Meenakshi Mission Hospital and Research Centre, Lake Area, Melur Road, Madurai,, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath